Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$12,673,103
+$137,243 QoQ
Shares Held
49,900
-2.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
3.76%
of 13F equity value
Holder Rank
#964
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROBERTS GLORE & CO INC /IL/ holds $30,036,472 across 10 Drug Manufacturers - General names. JNJ ranks #1 (42.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
49,900 | $12,673,103 | |
| 2 | ABBV |
AbbVie Inc.
|
29,453 | $7,411,552 | |
| 3 | AMGN |
Amgen Inc
|
6,771 | $2,451,914 | |
| 4 | NVS |
Novartis AG
|
12,498 | $1,958,686 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
9,885 | $1,248,870 | |
| 6 | NVO |
Novo Nordisk A S
|
25,727 | $1,233,352 | |
| 7 | PFE |
Pfizer Inc
|
39,351 | $947,572 | |
| 8 | MRK |
Merck & Co., Inc.
|
6,037 | $775,754 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,673,103 | 49,900 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $12,535,860 | 51,284 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $10,941,446 | 52,870 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $10,241,488 | 55,234 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $8,680,935 | 56,831 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $9,379,412 | 56,557 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $8,419,197 | 58,216 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $9,395,104 | 57,973 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,561,760 | 58,578 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,190,364 | 58,097 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,439,666 | 60,225 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $9,409,013 | 60,411 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $10,086,457 | 60,938 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,508,940 | 61,348 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $10,862,738 | 61,493 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,786,497 | 66,029 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $11,917,666 | 67,138 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $12,090,276 | 68,218 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $11,721,545 | 68,519 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $10,989,267 | 68,045 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $11,241,692 | 68,239 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $11,387,647 | 69,289 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $11,059,564 | 70,273 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $10,417,282 | 69,971 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $9,634,561 | 68,510 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $10,216,600 | 77,912 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||